UBS Group’s LifeMD LFMD Stock Holding History
Bought
Maintained
Sold
Other funds holding LFMD
VCM
RA
PGCM
BRF
UBS Group's LFMD Position: Q1 2026 in Review
UBS Group reduced its LifeMD (LFMD) stake by 58% in Q1 2026, selling an estimated $1.36M and leaving 282,095 shares worth $1.02M. The position accounts for ﹤0.01% of the portfolio, ranked #5544.
UBS Group first reported a position in LFMD in Q1 2021 and has held it in 16 quarters since. The position peaked at $12.8M in Q2 2025. 102 funds tracked by Wall St. Rank hold LFMD as of Q1 2026.
- UBS Group held 282,095 shares of LifeMD worth $1.02M as of Q1 2026.
- UBS Group sold 391,913 LifeMD shares in Q1 2026, an estimated $1.36M.
- LifeMD made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5544 holding.
- UBS Group first reported a position in LifeMD in Q1 2021 and has held it in 16 quarters since.
- UBS Group's LifeMD position peaked at $12.8M in Q2 2025.
- 102 funds tracked by Wall St. Rank held LifeMD as of Q1 2026.
Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.